EE Lower
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
Papers in
-
- Sarcoidosis and Beryllium Toxicity Research 4
-
- S100 Proteins and Annexins 1
- Histone Deacetylase Inhibitors Research 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- Beth Overmoyer (2 shared papers)Peter M. Ravdin (2 shared papers)Steven R. Olsen (2 shared papers)Leslie Rodgers Laufman (2 shared papers)W J Urba (2 shared papers)John K. Erban (2 shared papers)Robert Mennel (1 shared paper)Stephen E. Jones (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)European Journal of Cancer Supplements (1 paper)PubMed (4 papers)
- Partner nations
- United StatesCanada
In The Last Decade
EE Lower
6 papers receiving 581 citations
Peers
Comparison fields: 5 of 60
- Oncology 318
- Cancer Research 119
- Physiology 142
- Pulmonary and Respiratory Medicine 136
- Dermatology 37
Countries citing papers authored by EE Lower
This map shows the geographic impact of EE Lower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EE Lower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EE Lower more than expected).
Fields of papers citing papers by EE Lower
This network shows the impact of papers produced by EE Lower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EE Lower. The network helps show where EE Lower may publish in the future.
Co-authors
The 20 scholars most cited alongside EE Lower, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 420 | |
| 2 | Predicting respiratory failure in sarcoidosis patients. | 1997 | 95 |
| 3 | Alternatives to corticosteroids in the treatment of sarcoidosis. | 1997 | 33 |
| 4 | Paranoid psychosis due to neurosarcoidosis. | 1994 | 24 |
| 5 | 2003 | 22 | |
| 6 | The effect of cancer and chemotherapy on monocyte function. | 1990 | 10 |
| 7 | 2009 | 0 |
About EE Lower
EE Lower is a scholar working on Physiology, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 7 papers that have together received 604 indexed citations. Recurring topics across this work include Sarcoidosis and Beryllium Toxicity Research (4 papers), Cancer Treatment and Pharmacology (2 papers), Pulmonary Hypertension Research and Treatments (1 paper), S100 Proteins and Annexins (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Cancer therapeutics and mechanisms (1 paper) and Multiple Myeloma Research and Treatments (1 paper). The work is most often cited by research in Oncology (318 citations), Cancer Research (119 citations), Physiology (142 citations), Pulmonary and Respiratory Medicine (136 citations) and Dermatology (37 citations). EE Lower has collaborated with scholars based in United States and Canada. Frequent co-authors include Beth Overmoyer, Peter M. Ravdin, Steven R. Olsen, Leslie Rodgers Laufman, W J Urba, John K. Erban, Robert Mennel, Stephen E. Jones, Donald Richards and Kathleen I. Pritchard. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer Supplements and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.